张霞｜东北大学｜学者主页

2026

Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial

Xia Zhang, Rui-Ling Feng, Yi-Fan Wang, Wenqiang Fan, Xiao Gao, Miaomiao Ma, G. Gao, D. Jiang, Ting Li, Huifang Guo, Ling-Yan Lei, Ke Xu, Yu-Cui Li, Kuanting Wang, Yanli Ding, Wei Wei, Nan Zhang, Wen-Ping Pan, Qingwen Wang, Juan He, Yue-Ming Cai, Tong-Jun Mao, Ruijun Zhang, R. Mu, Yong-Fu Wang, Hui Wang, Yuan Jia, Xiao-Lin Sun, Zhan-Guo Li, Jing He

Nature Communications

精选作品

期刊论文

Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial

Identification of candidate biomarkers for diagnosis, disease activity, and relapse prediction in IgG4-related disease

Efficacy and safety of low-dose interleukin 2 for Behçet’s syndrome: a randomized, placebo-controlled, double-blind, phase 2 clinical trial

Identification of distinct subgroups in Chinese patients with Behçet’s syndrome via cluster analysis of immune cells and clinical features

Evaluating the therapeutic potential of tofacitinib in Sjögren's disease: a comprehensive clinical and immunological assessment.

DOSE-DEPENDENT EFFICACY AND SAFETY OF LOW-DOSE IL-2 IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

Low-dose interleukin-2 in the treatment of refractory relapsing polychondritis.

IL-2 detected by flow cytometry and its significance in systemic lupus erythematosus

[Flow cytometry analysis of normal range of natural killer cells and their subsets in peripheral blood of healthy Chinese adults].

Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis

Predictive biomarkers for low-dose IL-2 therapy efficacy in systemic lupus erythematosus: a clinical analysis

Immune skew of follicular helper T cells and effector T cells in patients with Sjögren’s syndrome

[Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].

Anti-carbonic anhydrase II antibody reflects urinary acidification defect especially in proximal renal tubules in patients with primary Sjögren syndrome

Study of 43 SLE patients with autoimmune liver cirrhosis: emphasis on clinical features and differences from lupus without cirrhosis

Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial

Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model

Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study

Biliary candidiasis mimicking IgG4‐related disease in a patient with normal immunity

Dynamics of T follicular helper cells in patients with rheumatic diseases and subsequent antibody responses in a three‐dose immunization regimen of CoronaVac

Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome

Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis

Treatment of Active Idiopathic Inflammatory Myopathies by Low-Dose Interleukin-2: A Prospective Cohort Pilot Study

Sonoelastography of salivary glands for diagnosis and clinical evaluation in primary Sjögren's syndrome.

Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus

Salivary gland ultrasonography in primary Sjögren’s syndrome from diagnosis to clinical stratification: a multicentre study

Clinical assessment of cardiac impairment favored by two-dimensional speckle tracking echocardiology in patients with systemic sclerosis.

Double Negative B Cell Is Associated With Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remission

[Analysis of 20-year survival rate and prognostic indicators of systemic lupus erythematosus].

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial

Interleukin-2 Deficiency Associated with Renal Impairment in Systemic Lupus Erythematosus

Tissue-Specific Autoantibodies Improve Diagnosis of Primary Sjögren's Syndrome in the Early Stage and Indicate Localized Salivary Injury

Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus

Systemic lupus erythematosus complicated by noncirrhotic portal hypertention: a clinical analysis and review of literature

Pathogenic conversion of regulatory B10 cells into osteoclast-priming cells in rheumatoid arthritis.

Characteristics of germinal center‐like structures in patients with Sjögren's syndrome

自己免疫疾患:全身性エリテマトーデス患者での低用量インターロイキン2投与はCD4+T細胞サブセットを選択的に変化させる

Hypoxia‐inducible factor‐1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis

Dietary intake and risk of rheumatoid arthritis—a cross section multicenter study

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

Assessment of the Stiffness of Major Salivary Glands in Primary Sjögren's Syndrome through Quantitative Acoustic Radiation Force Impulse Imaging.

Manifestations of primary Sjögren's syndrome associated lung involvement and its risk factors

[Analyses of 77 patients with hemophagocytic syndrome].

Eleven patients with macrophage activation syndrome: case reports

Ultrasonographic evaluation of major salivary glands in primary Sjögren's syndrome: comparison of two scoring systems.

[Significance of the detection of anti-v-raf murine sarcoma viral oncogene homologue B1 antibodies in the diagnostic practice of rheumatoid arthritis].

东北大学化学实验教学改革探索